RWE & Decentralized Clinical Trials

Brillex leverages real-world data and decentralized trial models to enhance clinical insights beyond traditional settings. Our post-marketing surveillance strategies help capture long-term safety and effectiveness, supporting informed regulatory and commercial decisions.

Real-World Evidence Generation
Decentralized Clinical Trials
Post-Marketing Surveillance

Real-World Evidence & Decentralized Trials

Explore Services

Clinical Trial Management (Phase I - IV) on Patients

Bioavailability & Bioequivalence (BA/BE) Studies

Pharmacovigilance & Safety Services

Regulatory Affairs & Quality Compliance

Medical Writing & Scientific Support

Data Management & Biostatistics

Site & Patient Recruitment Support

Clinical Trial Logistics & Supply Chain

Nitrosamine Testing Services

Inquiry Now!

(+91)

+93 Afghanistan
+355 Albania
+213 Algeria
+1684 American Samoa
+376 Andorra
+244 Angola
+1264 Anguilla
+672 Antarctica
+1268 Antigua And Barbuda
+54 Argentina
+374 Armenia
+297 Aruba
+61 Australia
+43 Austria
+994 Azerbaijan
+1242 Bahamas The
+973 Bahrain
+880 Bangladesh
+1246 Barbados
+375 Belarus
+32 Belgium
+501 Belize
+229 Benin
+1441 Bermuda
+975 Bhutan
+591 Bolivia
+387 Bosnia and Herzegovina
+267 Botswana
+55 Brazil
+246 British Indian Ocean Territory
+673 Brunei
+359 Bulgaria
+226 Burkina Faso
+257 Burundi
+855 Cambodia
+237 Cameroon
+1 Canada
+238 Cape Verde
+1345 Cayman Islands
+236 Central African Republic
+235 Chad
+56 Chile
+86 China
+61 Christmas Island
+672 Cocos (Keeling) Islands
+57 Colombia
+269 Comoros
+242 Congo
+242 Congo The Democratic Republic Of The
+682 Cook Islands
+506 Costa Rica
+225 Cote D'Ivoire (Ivory Coast)
+385 Croatia (Hrvatska)
+53 Cuba
+357 Cyprus
+420 Czech Republic
+45 Denmark
+253 Djibouti
+1767 Dominica
+1809 Dominican Republic
+593 Ecuador
+20 Egypt
+503 El Salvador
+240 Equatorial Guinea
+291 Eritrea
+372 Estonia
+251 Ethiopia
+500 Falkland Islands
+298 Faroe Islands
+679 Fiji Islands
+358 Finland
+33 France
+594 French Guiana
+689 French Polynesia
+241 Gabon
+220 Gambia The
+995 Georgia
+49 Germany
+233 Ghana
+350 Gibraltar
+30 Greece
+299 Greenland
+1473 Grenada
+590 Guadeloupe
+1671 Guam
+502 Guatemala
+224 Guinea
+245 Guinea-Bissau
+592 Guyana
+509 Haiti
+504 Honduras
+852 Hong Kong S.A.R.
+36 Hungary
+354 Iceland
+91 India
+62 Indonesia
+98 Iran
+964 Iraq
+353 Ireland
+972 Israel
+39 Italy
+1876 Jamaica
+81 Japan
+962 Jordan
+7 Kazakhstan
+254 Kenya
+686 Kiribati
+850 Korea North
+82 Korea South
+965 Kuwait
+996 Kyrgyzstan
+856 Laos
+371 Latvia
+961 Lebanon
+266 Lesotho
+231 Liberia
+218 Libya
+423 Liechtenstein
+370 Lithuania
+352 Luxembourg
+853 Macau S.A.R.
+389 Macedonia
+261 Madagascar
+265 Malawi
+60 Malaysia
+960 Maldives
+223 Mali
+356 Malta
+692 Marshall Islands
+596 Martinique
+222 Mauritania
+230 Mauritius
+269 Mayotte
+52 Mexico
+691 Micronesia
+373 Moldova
+377 Monaco
+976 Mongolia
+1664 Montserrat
+212 Morocco
+258 Mozambique
+95 Myanmar
+264 Namibia
+674 Nauru
+977 Nepal
+599 Netherlands Antilles
+31 Netherlands The
+687 New Caledonia
+64 New Zealand
+505 Nicaragua
+227 Niger
+234 Nigeria
+683 Niue
+672 Norfolk Island
+1670 Northern Mariana Islands
+47 Norway
+968 Oman
+680 Palau
+970 Palestinian Territory Occupied
+507 Panama
+675 Papua new Guinea
+595 Paraguay
+51 Peru
+63 Philippines
+64 Pitcairn Island
+48 Poland
+351 Portugal
+1787 Puerto Rico
+974 Qatar
+262 Reunion
+40 Romania
+70 Russia
+250 Rwanda
+290 Saint Helena
+1869 Saint Kitts And Nevis
+1758 Saint Lucia
+508 Saint Pierre and Miquelon
+1784 Saint Vincent And The Grenadines
+684 Samoa
+378 San Marino
+239 Sao Tome and Principe
+966 Saudi Arabia
+221 Senegal
+248 Seychelles
+232 Sierra Leone
+65 Singapore
+421 Slovakia
+386 Slovenia
+677 Solomon Islands
+252 Somalia
+27 South Africa
+500 South Georgia
+34 Spain
+94 Sri Lanka
+249 Sudan
+597 Suriname
+47 Svalbard And Jan Mayen Islands
+268 Swaziland
+46 Sweden
+41 Switzerland
+963 Syria
+886 Taiwan
+992 Tajikistan
+255 Tanzania
+66 Thailand
+228 Togo
+690 Tokelau
+676 Tonga
+1868 Trinidad And Tobago
+216 Tunisia
+90 Turkey
+7370 Turkmenistan
+1649 Turks And Caicos Islands
+688 Tuvalu
+256 Uganda
+380 Ukraine
+971 United Arab Emirates
+44 United Kingdom
+1 United States
+1 United States Minor Outlying Islands
+598 Uruguay
+998 Uzbekistan
+678 Vanuatu
+39 Vatican City State (Holy See)
+58 Venezuela
+84 Vietnam
+1284 Virgin Islands (British)
+1340 Virgin Islands (US)
+681 Wallis And Futuna Islands
+212 Western Sahara
+967 Yemen
+260 Zambia
+263 Zimbabwe

Real-World Evidence & Decentralized Trials

Brillex leverages real-world data and decentralized trial models to enhance clinical insights beyond traditional settings. Our post-marketing surveillance strategies help capture long-term safety and effectiveness, supporting informed regulatory and commercial decisions.

Explore Services

Inquiry Now!

Discover More

/

brillex-clinical-research-pvt-ltd